VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Ascletis Pharma (01672.HK): GIC Raises Stake to 7% — ASC30 US Phase II Enrollment Complete
Ascletis Pharma (01672.HK): GIC Raises Stake to 7% — ASC30 US Phase II Enrollment Complete
May 21, 2026 10:57 CST Updated 11:21
Share: